Inventor · disambiguated record
Nina E. Weisser
Also filed as: WEISSER NINA · WEISSER NINA E
8 granted patents·12 pending applications·30 citations·filing 2009–2024
82Inventor score
Files withZYMEWORKS BC INC8ZYMEWORKS INC8HALL J CHRISTOPHER2C/O ZYMEWORKS BC INC1HALL CHRISTOPHER J1
Top patents by PatentIndex Score
20 records- 0196US10000576B1Bispecific antigen-binding constructs targeting HER2ZYMEWORKS INC·Filed 2018·Granted Jun 19, 2018·23 cites·30 claims
- 0290US2025122305A1Bispecific antigen binding constructs targeting her2ZYMEWORKS BC INC·Filed 2024·Application pending·0 cites
- 0389US11325981B2Bispecific antigen-binding constructs targeting Her2ZYMEWORKS INC·Filed 2018·Granted May 10, 2022·2 cites·19 claims
- 0489US10947319B2Bispecific antigen-binding constructs targeting HER2ZYMEWORKS INC·Filed 2014·Granted Mar 16, 2021·5 cites·18 claims
- 0584US2024343802A1Bispecific Asymmetric Heterodimers Comprising Anti-CD3 ConstructsZYMEWORKS BC INC·Filed 2024·Application pending·0 cites
- 0681US12215166B2Bispecific antigen binding constructs targeting HER2ZYMEWORKS BC INC·Filed 2022·Granted Feb 4, 2025·0 cites·23 claims
- 0781US2025084184A1Methods of using bispecific antigen-binding constructs targeting her2ZYMEWORKS BC INC·Filed 2024·Application pending·0 cites
- 0876US11965036B2Bispecific antigen-binding constructs targeting HER2ZYMEWORKS BC INC·Filed 2021·Granted Apr 23, 2024·0 cites·19 claims
- 0971US2021317212A1Bispecific Asymmetric Heterodimers Comprising Anti-CD3 ConstructsZYMEWORKS INC·Filed 2021·Application pending·0 cites
- 1071US2025009788A1Methods of using a bispecific antigen-binding construct targeting her2 in combination with cdk4/6 inhibitors for the treatment of breast cancerZYMEWORKS BC INC·Filed 2024·Application pending·0 cites
- 1166US12157775B2Methods of using bispecific antigen-binding constructs targeting HER2ZYMEWORKS BC INC·Filed 2020·Granted Dec 3, 2024·0 cites·23 claims
- 1262US2012034223A1Methods of improving the therapeutic efficacy and utility of antibody fragmentsHALL CHRISTOPHER J·Filed 2009·Application pending·0 cites
- 1361US2021269553A1Methods using monovalent antigen binding constructs targeting her2ZYMEWORKS INC·Filed 2020·Application pending·0 cites
- 1461US2019248897A1Bispecific Asymmetric Heterodimers Comprising Anti-CD3 ConstructsZYMEWORKS INC·Filed 2019·Application pending·0 cites
- 1553US12304954B2Multivalent and bispecific antibody constructs and methods of use thereofZYMEWORKS BC INC·Filed 2024·Granted May 20, 2025·0 cites·30 claims
- 1653US2017355779A1Methods of using bispecific antigen-binding constructs targeting her2ZYMEWORKS INC·Filed 2015·Application pending·0 cites
- 1752US2016297891A1Methods using monovalent antigen binding constructs targeting her2ZYMEWORKS INC·Filed 2014·Application pending·0 cites
- 1850US12076400B2Methods of using a bispecific antigen-binding construct targeting HER2 in combination with CDK4/6 inhibitors for the treatment of breast cancerC/O ZYMEWORKS BC INC·Filed 2020·Granted Sep 3, 2024·0 cites·18 claims
- 1947US2014044712A1Methods of Improving the Therapeutic Efficacy and Utility of Antibody FragmentsHALL J CHRISTOPHER·Filed 2013·Application pending·0 cites
- 2041US2016215041A1Methods of Improving the Therapeutic Efficacy and Utility of Antibody FragmentsHALL J CHRISTOPHER·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nina E. Weisser files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →